Capex / revenue moved 233 bp higher
Capex / revenue changed +233 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed +233 basis points from the comparable as-filed period.
Capital expenditure changed +109.3% from the comparable as-filed period.
Cash & equivalents changed +28.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt changed -24.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +282 basis points from the comparable as-filed period.
Net income changed +92.1% from the comparable as-filed period.
Operating income changed +48.4% from the comparable as-filed period.
Operating margin changed +371 basis points from the comparable as-filed period.
Gross profit changed +18.8% from the comparable as-filed period.
Revenue changed +9.1% from the comparable as-filed period.
Selling, general & administrative changed +7.8% from the comparable as-filed period.
Inventory changed +3.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.